Extra-amniotic administration
Extra-amniotic administration is a route of administration to the space between the fetal membranes and endometrium inside the uterus of a pregnant woman.
It can be used to administer drugs affecting uterus motility, such as oxytocin and prostaglandins, e.g. in labor induction or medical abortion.[1]
References
- ↑ Gómez Ponce de León R, Wing DA (April 2009). "Misoprostol for termination of pregnancy with intrauterine fetal demise in the second and third trimester of pregnancy - a systematic review". Contraception. 79 (4): 259–71. doi:10.1016/j.contraception.2008.10.009. PMID 19272495.
| Oral |
| ||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ophthalmic, otologic, nasal | 
| ||||||||||||||||||||||
| Urogenital | |||||||||||||||||||||||
| Rectal (enteral) | |||||||||||||||||||||||
| Dermal | 
| ||||||||||||||||||||||
| |||||||||||||||||||||||
-solution.jpg.webp)
This article is issued from Offline. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.